2018
DOI: 10.1371/journal.pone.0193090
|View full text |Cite
|
Sign up to set email alerts
|

Patient preferences for Interferon-beta in Iran: A discrete choice experiment

Abstract: Multiple sclerosis is a chronic, progressive, and common disease affecting the central nervous system in young adults. Interferon-beta is one of the most widely used medicines to reduce the disease progression. Given the variety of drugs in this category, we aimed to identify the preferences of patients for IFN-β that play an important role in policymaking in this area. Discrete choice experiment method was used in the present study to identify and prioritize those attributes that are of interest to MS patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Disease-modifying therapies (DMTs) are available to decrease the frequency of relapses, to prevent neurologic disability and to limit the accumulation of focal white-matter lesions identifiable on magnetic resonance imaging (MRI). Nevertheless, there is no DMT that completely prevents or reverses the disease course [4].…”
Section: Introductionmentioning
confidence: 99%
“…Disease-modifying therapies (DMTs) are available to decrease the frequency of relapses, to prevent neurologic disability and to limit the accumulation of focal white-matter lesions identifiable on magnetic resonance imaging (MRI). Nevertheless, there is no DMT that completely prevents or reverses the disease course [4].…”
Section: Introductionmentioning
confidence: 99%
“…Subsequently, 12 scenarios (24 paired profiles) were created using fractional factorial to establish WTP (see Table ). In each scenario, there were two choices created by changing the levels of the attributes .…”
Section: Methodsmentioning
confidence: 99%